Analyst Price Target is C$3.20
▲ +∞ Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Opsens in the last 3 months. The average price target is C$3.20, with a high forecast of C$3.50 and a low forecast of C$2.90. The average price target represents a ∞ upside from the last price of C$0.00.
Current Consensus is
The current consensus among 3 contributing investment analysts is to moderate buy stock in Opsens. This Moderate Buy consensus rating has held steady for over two years.
Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada. As of December 12, 2023, Opsens Inc. operates as a subsidiary of Haemonetics Corporation.